APCD is a large-scale database system which collects health care claims data from different payer sources including most of health care providers. It combines data from all payers in a state, giving policymakers statewide information on costs, quality, utilization patterns, and both access and barriers to care, as well as numerous other health care measures.
The purpose of such database is to make it publically available to consumers and purchasers as well, providing it as a comparison tool for price and quality as they make health care decisions. APCDs are proving to be helpful tools, filling longstanding gaps in healthcare information. They are being used by 12 states (Colorado, Kansas, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, …show more content…
To make the system more transparent, the States are required to collect data using All Payers Claim Database (APCD) tool and compare price and quality of providers.
It directs the Director of the Agency for Healthcare Research and Quality to research and report to Congress on: (1) the types of information on the inpatient charges including hospital facilities, laboratory, medicine, surgeries and non-clinical services that individuals find useful in making decisions about where, when, and from whom to receive care; (2) how such types of information vary by hospitals to hospital and city to city, depending on healthcare coverage and benefits. (3) Identify ways to provide such information on a timely basis to consumers and providers to make sound decisions about healthcare facilities and …show more content…
Feasibility of the bill can be evaluated through the past efforts by the government to pass similar legislation. The price transparency issue first introduced in Congress in 2006, which was ignored as it was not a serious issue during that time. Similar legislation was rejected when Health subcommittee of the Energy and Commerce chairman Frank Pallone (D-NJ) was unsure of the unintended consequences of too much price transparency. In 2012, the healthcare price transparency act was never made its way from the committee on the basis of lack of evidence that transparency works to cut the cost of care. Also there were major outcries from the industry leaders like PhRMA and Large Medical
The purpose of such database is to make it publically available to consumers and purchasers as well, providing it as a comparison tool for price and quality as they make health care decisions. APCDs are proving to be helpful tools, filling longstanding gaps in healthcare information. They are being used by 12 states (Colorado, Kansas, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, …show more content…
To make the system more transparent, the States are required to collect data using All Payers Claim Database (APCD) tool and compare price and quality of providers.
It directs the Director of the Agency for Healthcare Research and Quality to research and report to Congress on: (1) the types of information on the inpatient charges including hospital facilities, laboratory, medicine, surgeries and non-clinical services that individuals find useful in making decisions about where, when, and from whom to receive care; (2) how such types of information vary by hospitals to hospital and city to city, depending on healthcare coverage and benefits. (3) Identify ways to provide such information on a timely basis to consumers and providers to make sound decisions about healthcare facilities and …show more content…
Feasibility of the bill can be evaluated through the past efforts by the government to pass similar legislation. The price transparency issue first introduced in Congress in 2006, which was ignored as it was not a serious issue during that time. Similar legislation was rejected when Health subcommittee of the Energy and Commerce chairman Frank Pallone (D-NJ) was unsure of the unintended consequences of too much price transparency. In 2012, the healthcare price transparency act was never made its way from the committee on the basis of lack of evidence that transparency works to cut the cost of care. Also there were major outcries from the industry leaders like PhRMA and Large Medical